和顺科技 reported revenue of ¥0.38B for the period ended 2026-06-30, +27.5% year on year. Net income was ¥0.01B, a 1.9% net margin on a 13.4% gross margin. The largest revenue line is 透明膜 at 55% of the total. Free cash flow for the period was ¥0.04B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.38B | +27.5% |
| Gross profit | ¥0.05B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.01B | — |
| Gross margin | 13.4% | Net margin 1.9% |
| Revenue Q/Q | +19.7% | — |
| Segment | Revenue | Share |
|---|---|---|
| 透明膜 | ¥0.21B | 54.5% |
| 有色光电基膜 | ¥0.14B | 37.6% |
| 其他功能膜 | ¥0.03B | 6.9% |
| 其他 | ¥0.00B | 1.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.33B | 86.6% |
| R&D | ¥0.01B | 3.8% |
| SG&A | ¥0.02B | 6.1% |
| Tax & other | ¥0.00B | 0.9% |
| Item | Amount |
|---|---|
| Total assets | ¥1.79B |
| Total liabilities | ¥0.61B |
| Shareholders' equity | ¥1.18B |
| Equity / assets | 65.8% |
| Operating cash flow | ¥0.05B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥0.04B |
| Cash conversion (OCF / net income) | -121% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
瑞泰新材 ・ 普瑞眼科 ・ 宏源药业 ・ 杰创智能 ・ 威尔高 ・ 同星科技 ・ 通力科技 ・ 华融化学 ・ 普蕊斯 ・ 富士莱 ・ 艾布鲁 ・ 格力博
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies